pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Approval · news · pharmadog
← back to Approval
News · Approval
1,552
stories
Jun 9, 26
GSK to acquire Nuvalent and its two cancer drugs under FDA review for $10.6B
endpoints
Jun 8, 26
Tango data add to growing momentum for pancreatic cancer drugs
biopharma dive
Jun 7, 26
#ADA26: 19% of Phase 3 patients quit Boehringer obesity shot over side effects
endpoints
Jun 5, 26
Generic drugmakers gain key victory in ‘skinny label’ patent case
biopharma dive
Jun 5, 26
Innovent declares Phase 3 success for ADC that attracted huge Takeda deal
endpoints
Jun 5, 26
STAT+: Will Makary’s FDA voucher program survive?
stat
Jun 5, 26
Tiny HHS office tasked with protecting research participants’ safety is running on fumes
stat
Jun 4, 26
Otsuka touts new IgAN evidence as it seeks full approval for Voyxact
endpoints
Jun 4, 26
Acting FDA chief isn't interested in permanent role
endpoints
Jun 4, 26
STAT+: Supreme Court backs generic drugmaker in ‘skinny labeling’ case
stat
Jun 4, 26
Hikma to funnel $267M to Ohio; Cingulate gets CRL for ADHD drug
endpoints
Jun 4, 26
An ADC specialist sinks on safety concerns for blood cancer drug
biopharma dive
Jun 4, 26
STAT+: Pharmalittle: We’re reading about fewer pharma investments in Germany, growing U.S. layoffs, and more
stat
Jun 4, 26
ADC Therapeutics' confirmatory data for Zynlonta muddied by death rates
endpoints
Jun 4, 26
STAT+: Does Revolution Medicines’ pancreatic cancer drug have even greater potential?
stat
Jun 3, 26
FDA guides pharma on explaining unapproved drugs to payors
endpoints
Jun 3, 26
Mineralys makes money moves before looming hypertension approval
endpoints
Jun 3, 26
STAT+: What the pope’s encyclical on AI means for Catholic hospitals, and all of health care
stat
Jun 3, 26
STAT+: Pharmalittle: We’re reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more
stat
Jun 2, 26
Fulcrum exploring a potential sale after FDA sidelined its sickle cell drug
biopharma dive
Jun 2, 26
STAT+: Radiopharmaceutical shows promise in post-Pluvicto setting
stat
Jun 2, 26
STAT+: Pharmalittle: We’re reading about a Lilly threat to 340B hospitals, Ebola vaccine funding, and more
stat
Jun 2, 26
AbiVax falls as safety worries cloud ‘landmark’ immune drug results
biopharma dive
Jun 2, 26
#ASCO26: Celcuity plans another FDA filing after positive breast cancer readout
endpoints
Jun 1, 26
STAT+: Eli Lilly warns hospitals to submit claims data in the next five days or lose their 340B drug discounts
stat
Jun 1, 26
Shionogi wins US approval for first pill to prevent Covid following exposure
endpoints
Jun 1, 26
Servier buys into muscular dystrophy with potentially $2.7B deal
biopharma dive
Jun 1, 26
As FDA misses deadline on electric shock ban, disability advocates speak out
stat
Jun 1, 26
STAT+: Pharmalittle: We’re reading about pancreatic and lung cancer drugs, China biotech growth, and more
stat
Jun 1, 26
The hidden history of BPC-157, a favorite MAHA peptide
stat
← prev
page 45 of 52
next →